Clinical Preventive Medicine
Time to Follow-up After Colorectal Cancer Screening by Health Insurance Type
The purpose of this study was to test the hypothesis that patients with Medicaid insurance or Medicaid-like coverage would have longer times to follow-up and be less likely to complete colonoscopy compared with patients with commercial insurance within the same healthcare systems.Follow-Up of Abnormal Breast and Colorectal Cancer Screening by Race/Ethnicity
Timely follow-up of abnormal tests is critical to the effectiveness of cancer screening, but may vary by screening test, healthcare system, and sociodemographic group.Awareness of Cancer Susceptibility Genetic Testing: The 2000, 2005, and 2010 National Health Interview Surveys
Genetic testing for several cancer susceptibility syndromes is clinically available; however, existing data suggest limited population awareness of such tests.Breast and Colorectal Cancer Screening: U.S. Primary Care Physicians' Reports of Barriers
Primary care physicians (PCPs) play a key role in performing and referring patients for cancer screening. Understanding barriers to test use is critical to developing strategies that promote adherence to clinical guidelines, but current literature does not distinguish the extent to which barriers may be similar or unique across screening modalities.
